153 related articles for article (PubMed ID: 26867978)
1. Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.
Kanakkanthara A; Northcote PT; Miller JH
Nat Prod Rep; 2016 Apr; 33(4):549-61. PubMed ID: 26867978
[TBL] [Abstract][Full Text] [Related]
2. Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.
Hood KA; West LM; Rouwé B; Northcote PT; Berridge MV; Wakefield SJ; Miller JH
Cancer Res; 2002 Jun; 62(12):3356-60. PubMed ID: 12067973
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity studies of the pelorusides: new congeners and semi-synthetic analogues.
Singh AJ; Razzak M; Teesdale-Spittle P; Gaitanos TN; Wilmes A; Paterson I; Goodman JM; Miller JH; Northcote PT
Org Biomol Chem; 2011 Jun; 9(12):4456-66. PubMed ID: 21512693
[TBL] [Abstract][Full Text] [Related]
4. Peloruside B, a potent antitumor macrolide from the New Zealand marine sponge Mycale hentscheli: isolation, structure, total synthesis, and bioactivity.
Singh AJ; Xu CX; Xu X; West LM; Wilmes A; Chan A; Hamel E; Miller JH; Northcote PT; Ghosh AK
J Org Chem; 2010 Jan; 75(1):2-10. PubMed ID: 19957922
[TBL] [Abstract][Full Text] [Related]
5. Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide.
Miller JH; Singh AJ; Northcote PT
Mar Drugs; 2010 Mar; 8(4):1059-79. PubMed ID: 20479967
[TBL] [Abstract][Full Text] [Related]
6. A unique mode of microtubule stabilization induced by peloruside A.
Huzil JT; Chik JK; Slysz GW; Freedman H; Tuszynski J; Taylor RE; Sackett DL; Schriemer DC
J Mol Biol; 2008 May; 378(5):1016-30. PubMed ID: 18405918
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interactions between peloruside A and other microtubule-stabilizing and destabilizing agents in cultured human ovarian carcinoma cells and murine T cells.
Wilmes A; O'Sullivan D; Chan A; Chandrahasen C; Paterson I; Northcote PT; La Flamme AC; Miller JH
Cancer Chemother Pharmacol; 2011 Jul; 68(1):117-26. PubMed ID: 20848285
[TBL] [Abstract][Full Text] [Related]
8. Molecular recognition of peloruside A by microtubules. The C24 primary alcohol is essential for biological activity.
Pera B; Razzak M; Trigili C; Pineda O; Canales A; Buey RM; Jiménez-Barbero J; Northcote PT; Paterson I; Barasoain I; Díaz JF
Chembiochem; 2010 Aug; 11(12):1669-78. PubMed ID: 20665616
[TBL] [Abstract][Full Text] [Related]
9. Peloruside A: a potent cytotoxic macrolide isolated from the new zealand marine sponge Mycale sp.
West LM; Northcote PT; Battershill CN
J Org Chem; 2000 Jan; 65(2):445-9. PubMed ID: 10813954
[TBL] [Abstract][Full Text] [Related]
10. Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines.
Wilmes A; Bargh K; Kelly C; Northcote PT; Miller JH
Mol Pharm; 2007; 4(2):269-80. PubMed ID: 17397239
[TBL] [Abstract][Full Text] [Related]
11. Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines.
Gaitanos TN; Buey RM; Díaz JF; Northcote PT; Teesdale-Spittle P; Andreu JM; Miller JH
Cancer Res; 2004 Aug; 64(15):5063-7. PubMed ID: 15289305
[TBL] [Abstract][Full Text] [Related]
12. βI-tubulin mutations in the laulimalide/peloruside binding site mediate drug sensitivity by altering drug-tubulin interactions and microtubule stability.
Kanakkanthara A; Rowe MR; Field JJ; Northcote PT; Teesdale-Spittle PH; Miller JH
Cancer Lett; 2015 Sep; 365(2):251-60. PubMed ID: 26052091
[TBL] [Abstract][Full Text] [Related]
13. Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells.
Wilmes A; Rawson P; Peng L; McLauchlan D; Northcote PT; Jordan TW; Miller JH
Invest New Drugs; 2011 Aug; 29(4):544-53. PubMed ID: 20107863
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly.
Hamel E; Day BW; Miller JH; Jung MK; Northcote PT; Ghosh AK; Curran DP; Cushman M; Nicolaou KC; Paterson I; Sorensen EJ
Mol Pharmacol; 2006 Nov; 70(5):1555-64. PubMed ID: 16887932
[TBL] [Abstract][Full Text] [Related]
15. The novel cytotoxic sponge metabolite peloruside A, structurally similar to bryostatin-1, has unique bioactivity independent of protein kinase C.
Hood KA; Bäckström BT; West LM; Northcote PT; Berridge MV; Miller JH
Anticancer Drug Des; 2001; 16(2-3):155-66. PubMed ID: 11962513
[TBL] [Abstract][Full Text] [Related]
16. Peloruside E (22-Norpeloruside A), a Pelorusane Macrolide from the New Zealand Marine Sponge Mycale hentscheli, Retains Microtubule-Stabilizing Properties.
Hong SW; Singh AJ; Patel V; Russell ER; Field JJ; Miller JH; Northcote PT
J Nat Prod; 2018 Sep; 81(9):2125-2128. PubMed ID: 30188708
[TBL] [Abstract][Full Text] [Related]
17. Induction of accelerated senescence by the microtubule-stabilizing agent peloruside A.
Chan A; Gilfillan C; Templeton N; Paterson I; Northcote PT; Miller JH
Invest New Drugs; 2017 Dec; 35(6):706-717. PubMed ID: 28733703
[TBL] [Abstract][Full Text] [Related]
18. Microtubule stabilization by peloruside A and paclitaxel rescues degenerating neurons from okadaic acid-induced tau phosphorylation.
Das V; Miller JH
Eur J Neurosci; 2012 Jun; 35(11):1705-17. PubMed ID: 22594877
[TBL] [Abstract][Full Text] [Related]
19. Computational comparison of microtubule-stabilising agents laulimalide and peloruside with taxol and colchicine.
Pineda O; Farràs J; Maccari L; Manetti F; Botta M; Vilarrasa J
Bioorg Med Chem Lett; 2004 Oct; 14(19):4825-9. PubMed ID: 15341932
[TBL] [Abstract][Full Text] [Related]
20. Structural insight into the role of Gln293Met mutation on the Peloruside A/Laulimalide association with αβ-tubulin from molecular dynamics simulations, binding free energy calculations and weak interactions analysis.
Zúñiga MA; Alderete JB; Jaña GA; Jiménez VA
J Comput Aided Mol Des; 2017 Jul; 31(7):643-652. PubMed ID: 28597356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
